A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer
type: MedicalStudy
description: An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B in Combination With 5-FU/FA and Oxaliplatin (Modified FOLFOX-6) as First-line Therapy in Patients With Metastatic Colorectal Cancer
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2009-04
end date: 2011-08
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00862784
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Eli Lilly and Company
study subject: Colorectal Carcinoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Colorectal Carcinoma

AI Analytics
type: Organization